thioxanthene-9-carbaldehyde | 28869-22-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻喃类
• 英文名称: thioxanthene-9-carbaldehyde
• 英文别名: 9H-thioxanthene-9-carbaldehyde
• CAS: 28869-22-9
• 化学式: C₁₄H₁₀OS
• 分子量: 226.299
• InChiKey: KFSNCEZMWWWSKZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  42.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  thioxanthene-9-carbaldehyde 在 sodium tetrahydroborate 作用下， 以 乙醇 为溶剂， 生成 thioxanthen-9-yl-methanol
  参考文献：
  名称：

  2-Substituted (2SR)-2-Amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 1. Effects of Alkyl, Arylalkyl, and Diarylalkyl Substitution

  摘要：

  In this paper, we describe the synthesis of a series of a-substituted analogues of the potent and selective group II metabotropic glutamate receptor (mGluR) agonist (1S,1'S,2'S)-carboxy-cyclopropylglycine (2, L-CCG 1). Incorporation of a substituent on the amino acid carbon converted the agonist 2 into antagonist. Ail of the compounds were prepared and tested as a series of four isomers, i.e., two racemic diastereomers. We explored alkyl substitution, both normal and terminally branched; phenylalkyl and diphenylalkyl substitution; and a variety of aromatic and carbocyclic surrogates for phenyl. Affinity for group II mGluRs was measured using [H-3]glutamic acid (Glu) binding in rat forebrain membranes. Antagonist activity was confirmed for these compounds by measuring their ability to antagonize (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid-induced inhibition of forskolin-stimulated cyclic-AMP in RGT cells transfected with human mGluR2 and mGluR3. We found that while alkyl substitution provided no increase in affinity relative to 2, phenylethyl and diphenylethyl substitution, as in 105 and 109, respectively, were quite beneficial, The affinity of 109 was further enhanced when the two aromatic rings were joined by an oxygen or sulfur atom to form the tricyclic xanthylmethyl and thioxanthylmethyl amino acids 113 and 114, respectively. Amino acid 113, with an IC50 of 0.10 mu M in the [H-3]Glu binding assay, was 52-fold more patent than 2, whose IC50 was 0.47 mu M.

  DOI：

  10.1021/jm970497w
• 作为产物：
  描述：

  9-噻吨酮 在 高氯酸 、 sodium hexamethyldisilazane 作用下， 以 1,4-二氧六环 、 乙醚 为溶剂， 生成 thioxanthene-9-carbaldehyde
  参考文献：
  名称：

  2-Substituted (2SR)-2-Amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 1. Effects of Alkyl, Arylalkyl, and Diarylalkyl Substitution

  摘要：

  In this paper, we describe the synthesis of a series of a-substituted analogues of the potent and selective group II metabotropic glutamate receptor (mGluR) agonist (1S,1'S,2'S)-carboxy-cyclopropylglycine (2, L-CCG 1). Incorporation of a substituent on the amino acid carbon converted the agonist 2 into antagonist. Ail of the compounds were prepared and tested as a series of four isomers, i.e., two racemic diastereomers. We explored alkyl substitution, both normal and terminally branched; phenylalkyl and diphenylalkyl substitution; and a variety of aromatic and carbocyclic surrogates for phenyl. Affinity for group II mGluRs was measured using [H-3]glutamic acid (Glu) binding in rat forebrain membranes. Antagonist activity was confirmed for these compounds by measuring their ability to antagonize (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid-induced inhibition of forskolin-stimulated cyclic-AMP in RGT cells transfected with human mGluR2 and mGluR3. We found that while alkyl substitution provided no increase in affinity relative to 2, phenylethyl and diphenylethyl substitution, as in 105 and 109, respectively, were quite beneficial, The affinity of 109 was further enhanced when the two aromatic rings were joined by an oxygen or sulfur atom to form the tricyclic xanthylmethyl and thioxanthylmethyl amino acids 113 and 114, respectively. Amino acid 113, with an IC50 of 0.10 mu M in the [H-3]Glu binding assay, was 52-fold more patent than 2, whose IC50 was 0.47 mu M.

  DOI：

  10.1021/jm970497w

文献信息

• [EN] POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) INHIBITORS AGAINST COVID MACRODOMAIN AND METHODS OF USING THE SAME<br/>[FR] INHIBITEURS DE LA POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) DIRIGÉS CONTRE LE MACRODOMAINE DU CORONAVIRUS ET PROCÉDÉS D'UTILISATION DE CEUX-CI
  申请人：UNIV TEXAS

  公开号：WO2022159818A1

  公开（公告）日：2022-07-28

  The present disclosure provides compounds of Formula (Ia) and Formula (Ib) and the pharmaceutically acceptable salts and solvates thereof, wherein A1, A2, R1, R2, R3, and R4are defined as set forth in the specification. The present disclosure also provides the use of compounds of Formula (Ia) or Formula (Ib) to treat a coronavirus infection in a subject.

  本公开提供公式（Ia）和公式（Ib）的化合物及其药学上可接受的盐和溶剂化物，其中A1、A2、R1、R2、R3和R4的定义如规范中所述。本公开还提供使用公式（Ia）或公式（Ib）的化合物治疗受冠状病毒感染的主体的方法。
• 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE
  申请人：BASF AKTIENGESELLSCHAFT

  公开号：EP0691962A1

  公开（公告）日：1996-01-17
• SMALL MOLECULE PARG INHIBITORS AND METHODS OF USE THEREOF
  申请人：Board of Regents, The University of Texas System

  公开号：EP3947351A2

  公开（公告）日：2022-02-09
• US5622953A
  申请人：——

  公开号：US5622953A

  公开（公告）日：1997-04-22
• [EN] 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE<br/>[FR] DERIVES DE 1-AMINO-3-PHENOXY-PROPANE EN TANT QUE MODULATEURS DE LA RESISTANCE A DES AGENTS THERAPEUTIQUES MULTIPLES
  申请人：BASF AKTIENGESELLSCHAFT

  公开号：WO1994022842A1

  公开（公告）日：1994-10-13

  (EN) This invention relates to 1-amino-3-phenoxy-propane-derivatives of formula (1) (in which A, B, R, Rx, X and Z are defined as in the specification described) and methods for their preparation. These compounds may be used as modulators of multi-drug resistance in cancer chemotherapy and for circumvention of resistance in the treatment of malaria.(FR) L'invention concerne des dérivés de 1-amino-3-phénoxy-propane représentés par la formule (1), où A, B, R, Rx, X et Z sont définis selon la spécification décrite, ainsi que des procédés servant à leur préparation. Lesdits composés peuvent s'utiliser en tant que modulateurs de la résistance à des agents thérapeutiques multiples dans la chimiothérapie anticancéreuse, ainsi que pour lutter contre la résistance au traitement de la malaria.